Page 2 - பாஸ்கல் நீகெண் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாஸ்கல் நீகெண். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாஸ்கல் நீகெண் Today - Breaking & Trending Today

Doré Copper Mining to Present at Alpha Bronze Virtual Town Hall


Doré Copper Mining to Present at Alpha Bronze Virtual Town Hall
NEW YORK, NY / ACCESSWIRE / April 13, 2021 / Alpha Bronze, LLC ( Alpha Bronze ), is pleased to announce that Doré Copper Mining (TSXV:DCMC)(OTCQB:DRCMF) ( Doré Copper or the Company ), a copper-gold explorer and developer in the Chibougamau area of Québec, will be presenting at Alpha Bronze Virtual Town Hall on Wednesday, April 14, 2021 at 12:00 PM ET.
Mr. Ernest Mast, Chief Executive Officer of Doré Copper will give an overview of the Company, its hub-and-spoke development strategy built on advancing its high-grade copper-gold brownfield projects towards a restart of operations. Mr. Mast will respond to Investors questions thereafter. ....

New York , United States , Town Hall , Pascal Nigen , Alpha Bronze , Copper Mining , Alpha Bronze Virtual Town Hall , Ernest Mast , Chief Executive Officer , Virtual Town Hall , Dor 233 , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , நகரம் மண்டபம் , பாஸ்கல் நீகெண் , ஆல்பா வெண்கலம் , தாமிரம் சுரங்க , ஆல்பா வெண்கலம் மெய்நிகர் நகரம் மண்டபம் , அர்நெஸ்ட் மாஸ்ட் , தலைமை நிர்வாகி அதிகாரி , மெய்நிகர் நகரம் மண்டபம் ,

Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results


Press release content from Accesswire. The AP news staff was not involved in its creation.
Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results
March 16, 2021 GMT
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX: HBP ), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second .
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX: HBP ), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second .
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:“HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second quarter ended January 31, 2021. ....

Richmond Hill , Frank Michalargias , Pascal Nigen , Attributable To Helix Biopharma Corp , Alpha Bronze , Helix Biopharma Corp , Company Interim Condensed Statement Of Financial Position , Company Interim Condensed Financial , Company Interim Condensed Statement Of Net Loss , Helix Biopharma , Interim Condensed Statement , Net Loss , Comprehensive Loss , Condensed Statements , Financial Position , Condensed Statement , Interim Condensed Financial Statements , Chief Financial , Looking Statements , Annual Information Form , Government Business And Finance , Products And Services , Government Regulations , New Products And Services , Banking And Credit Regulation , Coronavirus Pandemic ,